DK1531839T3 - Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet - Google Patents
Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitetInfo
- Publication number
- DK1531839T3 DK1531839T3 DK03760696.9T DK03760696T DK1531839T3 DK 1531839 T3 DK1531839 T3 DK 1531839T3 DK 03760696 T DK03760696 T DK 03760696T DK 1531839 T3 DK1531839 T3 DK 1531839T3
- Authority
- DK
- Denmark
- Prior art keywords
- aggressiveness
- anxiety
- pheromones
- soothing
- bird
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38976802P | 2002-06-19 | 2002-06-19 | |
| EP02291533 | 2002-06-19 | ||
| PCT/EP2003/007144 WO2004000336A1 (en) | 2002-06-19 | 2003-06-19 | Avian appeasing pheromones to decrease stress, anxiety and aggressiveness |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1531839T3 true DK1531839T3 (da) | 2010-09-13 |
Family
ID=42635094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03760696.9T DK1531839T3 (da) | 2002-06-19 | 2003-06-19 | Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1531839B1 (https=) |
| JP (1) | JP4863619B2 (https=) |
| CN (1) | CN100508968C (https=) |
| AT (1) | ATE468123T1 (https=) |
| AU (1) | AU2003246372B8 (https=) |
| BR (1) | BRPI0311934B1 (https=) |
| CA (1) | CA2490681C (https=) |
| DK (1) | DK1531839T3 (https=) |
| ES (1) | ES2345099T3 (https=) |
| MX (1) | MXPA04013005A (https=) |
| PT (1) | PT1531839E (https=) |
| WO (1) | WO2004000336A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6629286B2 (ja) * | 2014-03-18 | 2020-01-15 | アンスティテュ・ドゥ・ルシェルシュ・アン・セミオシミー・エ・エソロジー・アプリケＩｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｈｅｒｃｈｅ Ｅｎ Ｓｅｍｉｏｃｈｉｍｉｅ Ｅｔ Ｅｔｈｏｌｏｇｉｅ Ａｐｐｌｉｑｕｅｅ | ネコ鎮静フェロモン |
| AU2016221929A1 (en) * | 2015-02-20 | 2017-07-13 | Société des Produits Nestlé S.A. | Medium chain fatty acids and their triglycerides for treating anxiety |
| US9943480B2 (en) * | 2015-11-03 | 2018-04-17 | Wisconsin Alumni Research Foundation | Compositions containing preen oil and methods of use thereof |
| BE1023693B1 (nl) * | 2016-06-15 | 2017-06-16 | Vervaeke-Belavi Nv | Werkwijze voor het produceren van kuikens |
| EP3727457B1 (fr) | 2017-12-22 | 2025-08-20 | Ceva Santé Animale | Diffuseurs de composition de semio-chimiques régulés en fonction de la température |
| CN117919345A (zh) * | 2023-12-21 | 2024-04-26 | 宁波三生生物科技股份有限公司 | 一种信息素组合物及其制备方法 |
| CN120938981A (zh) * | 2025-10-20 | 2025-11-14 | 宁波三生生物科技股份有限公司 | 一种信息素组合物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3039817B2 (ja) * | 1990-09-28 | 2000-05-08 | 株式会社資生堂 | シャンプー組成物 |
| US5272134A (en) * | 1992-03-24 | 1993-12-21 | Erox Corporation | Fragrance compositions and other compositions which contain human pheromones |
| FR2715069B1 (fr) * | 1994-01-20 | 1996-04-05 | Rene Laversanne | Procédé pour améliorer la rémanence d'une odeur. |
| DE19511572C2 (de) * | 1995-03-29 | 1998-02-26 | Henkel Kgaa | Niedrigviskose Trübungsmittelkonzentrate |
| DE19615777C2 (de) * | 1996-04-20 | 1999-04-01 | Henkel Kgaa | Verwendung von Milchsäure-Milchsäureester-Mischungen |
| GB9720814D0 (en) * | 1997-10-01 | 1997-12-03 | Kiotech Limited | Pheromone composition |
| JP4754688B2 (ja) * | 1998-01-21 | 2011-08-24 | フィドゥラン | ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン |
| US6054481A (en) * | 1998-01-21 | 2000-04-25 | Fideline | Pig appeasing pheromones for enhancing weight gain in a mammal |
| NO308197B1 (no) * | 1998-01-21 | 2000-08-14 | Fideline | Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav |
| DK1382343T3 (da) * | 1998-11-02 | 2010-04-26 | Gilead Sciences Inc | Kombinationsterapi til behandling af hepatitis B-virus |
-
2003
- 2003-06-19 MX MXPA04013005A patent/MXPA04013005A/es active IP Right Grant
- 2003-06-19 AT AT03760696T patent/ATE468123T1/de active
- 2003-06-19 CN CNB038172968A patent/CN100508968C/zh not_active Expired - Fee Related
- 2003-06-19 EP EP03760696A patent/EP1531839B1/en not_active Expired - Lifetime
- 2003-06-19 DK DK03760696.9T patent/DK1531839T3/da active
- 2003-06-19 JP JP2004514864A patent/JP4863619B2/ja not_active Expired - Fee Related
- 2003-06-19 AU AU2003246372A patent/AU2003246372B8/en not_active Ceased
- 2003-06-19 ES ES03760696T patent/ES2345099T3/es not_active Expired - Lifetime
- 2003-06-19 WO PCT/EP2003/007144 patent/WO2004000336A1/en not_active Ceased
- 2003-06-19 PT PT03760696T patent/PT1531839E/pt unknown
- 2003-06-19 CA CA2490681A patent/CA2490681C/en not_active Expired - Lifetime
- 2003-06-19 BR BRPI0311934-3A patent/BRPI0311934B1/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003246372B8 (en) | 2009-03-26 |
| JP2006508038A (ja) | 2006-03-09 |
| BR0311934A (pt) | 2005-04-05 |
| BRPI0311934B1 (pt) | 2015-05-26 |
| CA2490681C (en) | 2012-01-24 |
| CN1668318A (zh) | 2005-09-14 |
| ATE468123T1 (de) | 2010-06-15 |
| CN100508968C (zh) | 2009-07-08 |
| EP1531839A1 (en) | 2005-05-25 |
| WO2004000336A1 (en) | 2003-12-31 |
| EP1531839B1 (en) | 2010-05-19 |
| PT1531839E (pt) | 2010-07-21 |
| JP4863619B2 (ja) | 2012-01-25 |
| AU2003246372B2 (en) | 2008-11-27 |
| MXPA04013005A (es) | 2005-09-12 |
| CA2490681A1 (en) | 2003-12-31 |
| AU2003246372A1 (en) | 2004-01-06 |
| ES2345099T3 (es) | 2010-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0515316A (pt) | compostos de imidazoquinolina | |
| AP2001002217A0 (en) | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids. | |
| AR047529A1 (es) | Compuestos de quinolina sustituidos | |
| CY1116700T1 (el) | Παρασκευη συνθετικου χολικου οξεος | |
| NO980282L (no) | Beroligende feromoner for å minske stress, angst og aggresivitet hos griser | |
| ES2045017T3 (es) | Derivado de benzotiazol, su utilizacion y compuestos farmaceuticos que lo comprenden. | |
| ECSP067110A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica | |
| ATE304368T1 (de) | Kräuterpflanzen enthaltende artzneimittel | |
| CL2012002705A1 (es) | Composicion farmaceutica que comprende: a) 0,1-20% de ropivacaina,bupivacaina o levobupivacaina, b) 15 a 70% en peso de un monoglicerido de acido graso de cadena larga o sus mezclas, c) 5 a 60% de un acido graso libre saturado o instaurado de cadena larga y d)menos de 30% de agua; uso para reducir el dolor. | |
| DK1531839T3 (da) | Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet | |
| ECSP045493A (es) | Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a | |
| ATE396697T1 (de) | Zuckerlacton enthaltende zusammensetzung zur haarbehandlung | |
| BRPI0510526A (pt) | formulações lìquidas estabilizadas de interferon | |
| UY28148A1 (es) | Bromhidrato de escitalopram y un metodo para su preparacion | |
| ATE444739T1 (de) | Polymerzusammensetzung sowie diese enthaltende darreichungsformen | |
| ATE406415T1 (de) | Silikonmemulsion, verfahren zu ihrer herstellung und kosmetischer bestandteil | |
| ATE357934T1 (de) | Pharmazeutische zusammensetzung zur verhinderung der entwicklung und progression von mykotischen hautoberflächenerkrankungen | |
| BRPI0415163A (pt) | composição de xampu e usos de uma combinação de cera de abelha e silicone | |
| TN2010000058A1 (fr) | Composition therapeutique aromatisee a base d'argile | |
| DE69927260D1 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
| AR116869A1 (es) | Método de preparación de hidrolizado de concentrado de proteína de soja | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
| EP1131338A4 (en) | PROCESS FOR PRODUCING HIGHLY PURIFIED INVASINATED PROTEIN AND USE OF SUCH PROTEIN | |
| CY1107277T1 (el) | Βενζισοξαζολες | |
| ATE374811T1 (de) | Hühner-astrovirus typ 2 |